• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

已知患有坏疽性脓皮病的患者在接受某些治疗后发生坏疽性脓皮病的风险:一项回顾性分析。

Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis.

机构信息

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

出版信息

J Am Acad Dermatol. 2018 Feb;78(2):310-314.e1. doi: 10.1016/j.jaad.2017.09.040. Epub 2017 Sep 22.

DOI:10.1016/j.jaad.2017.09.040
PMID:28947285
Abstract

BACKGROUND

The risk of postoperative pyoderma gangrenosum (PG) in patients with a known history of PG is unknown.

OBJECTIVE

To quantify risk and identify patient- and/or procedure-related risk factors for postsurgical recurrence or exacerbation of PG in patients with a known history of PG.

METHODS

We retrospectively evaluated the likelihood of postsurgical recurrence or exacerbation of PG for all patients with a confirmed diagnosis of PG at Brigham and Women's Hospital and Massachusetts General Hospital from 2000 to 2015.

RESULTS

In all, 5.5% of procedures (n = 33) led to recurrence of PG in 15.1% of patients (n = 25). Compared with skin biopsy, small open surgical procedures had an adjusted odds ratio (aOR) of 8.65 (95% confidence interval [CI], 1.55-48.33) for PG recurrence or exacerbation; large open surgical procedures had an aOR of 5.97 (95% CI, 1.70-21.00); and Mohs micrographic surgery/skin excision had an aOR of 6.47 (95% CI, 1.77-23.61). PG chronically present at the time of the procedure had an aOR of 4.58 (95% CI, 1.72-12.22). Immunosuppression, time elapsed since the original PG diagnosis, and procedure location did not significantly influence risk.

LIMITATIONS

Our study is limited by its retrospective nature and relatively small sample size.

CONCLUSION

There is a small but clinically meaningful risk for postsurgical recurrence or exacerbation of PG in patients with a known history of PG; higher risks occur with more invasive procedures and chronically present PG.

摘要

背景

已知患有坏疽性脓皮病(PG)病史的患者术后发生 PG 的风险未知。

目的

量化风险,并确定患有已知 PG 病史的患者术后 PG 复发或恶化的与患者和/或手术相关的危险因素。

方法

我们回顾性评估了 2000 年至 2015 年期间在布莱根妇女医院和马萨诸塞州综合医院确诊患有 PG 的所有患者发生术后 PG 复发或恶化的可能性。

结果

所有手术中有 5.5%(n=33)导致 15.1%(n=25)的患者 PG 复发。与皮肤活检相比,小的开放性手术 PG 复发或恶化的调整比值比(aOR)为 8.65(95%置信区间[CI],1.55-48.33);大的开放性手术为 5.97(95%CI,1.70-21.00);Mohs 显微外科/皮肤切除术为 6.47(95%CI,1.77-23.61)。手术时 PG 持续存在的患者 aOR 为 4.58(95%CI,1.72-12.22)。免疫抑制、PG 确诊后时间间隔以及手术部位并未显著影响风险。

局限性

本研究受限于回顾性设计和相对较小的样本量。

结论

已知患有 PG 病史的患者术后 PG 复发或恶化的风险虽小,但具有临床意义;更具侵袭性的手术和慢性 PG 会增加风险。

相似文献

1
Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis.已知患有坏疽性脓皮病的患者在接受某些治疗后发生坏疽性脓皮病的风险:一项回顾性分析。
J Am Acad Dermatol. 2018 Feb;78(2):310-314.e1. doi: 10.1016/j.jaad.2017.09.040. Epub 2017 Sep 22.
2
Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014.术后坏疽性脓皮病(PG):1994 年至 2014 年 20 年期间梅奥诊所的经验。
J Am Acad Dermatol. 2015 Oct;73(4):615-22. doi: 10.1016/j.jaad.2015.06.054. Epub 2015 Jul 21.
3
Postoperative Pyoderma Gangrenosum: A Clinical Review of Published Cases.术后坏疽性脓皮病:已发表病例的临床综述。
Mayo Clin Proc. 2016 Sep;91(9):1267-79. doi: 10.1016/j.mayocp.2016.05.001. Epub 2016 Jul 31.
4
Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients.坏疽性脓皮病:103 例患者的回顾性分析,包括患者特征、合并症和治疗。
Br J Dermatol. 2011 Dec;165(6):1244-50. doi: 10.1111/j.1365-2133.2011.10565.x.
5
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
6
Chronic renal comorbidities in pyoderma gangrenosum: a retrospective cohort study.坏疽性脓皮病的慢性肾脏合并症:一项回顾性队列研究。
Immunol Res. 2021 Jun;69(3):249-254. doi: 10.1007/s12026-021-09187-3. Epub 2021 Apr 22.
7
Pyoderma gangrenosum demographics, treatments, and outcomes: an analysis of 2,273 cases.坏疽性脓皮病的人口统计学特征、治疗方法及治疗结果:2273例病例分析
J Wound Care. 2018 Jan 1;27(Sup1):S4-S8. doi: 10.12968/jowc.2018.27.Sup1.S4.
8
[Pathergic postsurgical-induced Pyoderma gangrenosum].[术后诱发的坏疽性脓皮病性超敏反应]
Rev Med Liege. 2017 May;72(5):227-232.
9
Case Study on Management of Postsurgical Pyoderma Gangrenosum After Spinal Surgery.脊柱手术后坏疽性脓皮病的术后管理病例研究。
J Wound Ostomy Continence Nurs. 2019 Nov/Dec;46(6):543-546. doi: 10.1097/WON.0000000000000587.
10
Consecutive Cases of Pyoderma Gangrenosum Following Dermatologic Surgery.皮肤科手术后发生的连续性坏疽性脓皮病病例
J Clin Aesthet Dermatol. 2020 Aug;13(8):49-50. Epub 2020 Aug 1.

引用本文的文献

1
Pyoderma Gangrenosum of the Breast: A Diagnostic Challenge.乳房坏疽性脓皮病:一项诊断挑战。
Breast Care (Basel). 2025 Jun;20(3):182-188. doi: 10.1159/000544905. Epub 2025 Feb 26.
2
Case Report: Spesolimab for pyoderma gangrenosum in an undifferentiated oligoarthritis patient receiving anti-IL-17 therapy.病例报告:司妥昔单抗用于一名接受抗IL-17治疗的未分化寡关节炎患者的坏疽性脓皮病
Front Immunol. 2025 Apr 7;16:1581996. doi: 10.3389/fimmu.2025.1581996. eCollection 2025.
3
Pyoderma Gangrenosum, a Challenging Postpartum Diagnosis-Case Report and Literature Review.
坏疽性脓皮病:产后诊断的挑战——病例报告与文献综述
J Clin Med. 2024 Jun 22;13(13):3653. doi: 10.3390/jcm13133653.
4
Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management.坏疽性脓皮病、痤疮和化脓性汗腺炎(PASH)综合征:单机构病例系列,重点关注治疗。
Arch Dermatol Res. 2024 Jun 15;316(7):397. doi: 10.1007/s00403-024-03125-7.
5
Clinical features and treatment outcomes of non-peristomal pyoderma gangrenosum in 59 patients at an academic institution from 2002 to 2021.2002年至2021年某学术机构59例非造口周围坏疽性脓皮病的临床特征及治疗结果
Arch Dermatol Res. 2024 Jun 8;316(7):375. doi: 10.1007/s00403-024-02960-y.
6
Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum.围手术期管理及造口周围坏疽性脓皮病的临床转归。
Arch Dermatol Res. 2024 Mar 6;316(4):98. doi: 10.1007/s00403-024-02826-3.
7
Postsurgical Pyoderma Gangrenosum Requiring Plastic Surgical Intervention: A Practical Review.需要整形外科干预的术后坏疽性脓皮病:实用综述
Plast Reconstr Surg Glob Open. 2024 Jan 19;12(1):e5505. doi: 10.1097/GOX.0000000000005505. eCollection 2024 Jan.
8
Infection mimicking skin condition: pyoderma gangrenosum.感染性酷似皮肤病:坏疽性脓皮病。
BMJ Case Rep. 2022 Aug 5;15(8):e247770. doi: 10.1136/bcr-2021-247770.
9
Practical aspects of the diagnosis and management of pyoderma gangrenosum.坏疽性脓皮病诊断与管理的实践要点
Front Med (Lausanne). 2023 Feb 14;10:1134939. doi: 10.3389/fmed.2023.1134939. eCollection 2023.
10
Dermatological manifestations of hematologic neoplasms. Part II: nonspecific skin lesions/paraneoplastic diseases.血液系统恶性肿瘤的皮肤表现。第二部分:非特异性皮肤损害/副肿瘤性疾病。
An Bras Dermatol. 2023 Mar-Apr;98(2):141-158. doi: 10.1016/j.abd.2022.08.005. Epub 2023 Jan 20.